JFG
ABEO icon

Jefferies Financial Group’s Abeona Therapeutics ABEO Stock Holding History

Jefferies Financial Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,000
Closed -$85.7K – 1248
2025
Q1 		$85.7K Hold
18,000
– – ﹤0.01% 1481
2024
Q4 		$100K Hold
18,000
– – ﹤0.01% 1457
2024
Q3 		$114K Buy
+18,000
New +$94K ﹤0.01% 1276

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Jefferies Financial Group's ABEO Position: Q2 2025 in Review

Jefferies Financial Group sold out of Abeona Therapeutics (ABEO) in Q2 2025, closing a stake of 18,000 shares — an estimated $85.7K sold.

Jefferies Financial Group first reported a position in ABEO in Q3 2024 and held it in 3 quarters. The position peaked at $114K in Q3 2024. 95 funds tracked by Wall St. Rank hold ABEO as of Q2 2025.

  • Jefferies Financial Group reported no remaining Abeona Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Jefferies Financial Group sold 18,000 Abeona Therapeutics shares in Q2 2025, an estimated $85.7K.
  • Jefferies Financial Group first reported a position in Abeona Therapeutics in Q3 2024 and held it in 3 quarters.
  • Jefferies Financial Group's Abeona Therapeutics position peaked at $114K in Q3 2024.
  • 95 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2025.

Based on Jefferies Financial Group's 13F filing for Q2 2025, filed 12 Aug 2025.